Danaher Corporation (ETR:DAP)
172.20
-3.76 (-2.14%)
Apr 24, 2025, 5:35 PM CET
Danaher Revenue
Danaher had revenue of $5.74B USD in the quarter ending March 28, 2025, a decrease of -0.95%. This brings the company's revenue in the last twelve months to $23.82B, up 0.35% year-over-year. In the year 2024, Danaher had annual revenue of $23.88B, down -0.06%.
Revenue (ttm)
$23.82B
Revenue Growth
+0.35%
P/S Ratio
5.63
Revenue / Employee
$378.10K
Employees
63,000
Market Cap
123.85B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 23.88B | -15.00M | -0.06% |
Dec 31, 2023 | 23.89B | -2.75B | -10.33% |
Dec 31, 2022 | 26.64B | 1.84B | 7.42% |
Dec 31, 2021 | 24.80B | 2.52B | 11.30% |
Dec 31, 2020 | 22.28B | 4.37B | 24.42% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Danaher News
- 7 days ago - $100 Invested In Danaher 10 Years Ago Would Be Worth This Much Today - Benzinga
- 10 days ago - Smart Money Is Betting Big In DHR Options - Benzinga
- 19 days ago - Lightning Round: Robinhood has more downside from here, says Jim Cramer - CNBC
- 22 days ago - 3 Wide-Moat Dividend Stars For A Championship Portfolio - Seeking Alpha
- 23 days ago - Becton Dickinson in talks with rivals over divesting life sciences unit - Financial Times
- 23 days ago - Danaher: Operational Excellence Meets Cyclical Pause - A Hold Amid Recovery Prospects - Seeking Alpha
- 24 days ago - Danaher Corporation: A Mixed Bag Of Strength And Stagnation - Seeking Alpha
- 24 days ago - Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations - Seeking Alpha